Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Institutional Investor Meeting - Plant Visit

Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Limited) has announced an institutional investor meeting in the form of a plant visit scheduled for June 29, 2026, at its Ankleshwar, Gujarat facility. This visit, which may be a group or one-on-one meeting, is to facilitate engagement with institutional investors. The company noted that the schedule and mode could change due to exigencies.